News
Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
Key Points
- Interested in Everpure, Inc.? Here are five stocks we like better.
- Everpure posted Q1 FY2027 revenue of $1.05 billion, representing over 35% year-over-year growth, its fastest rate in
Alico Exits Citrus as $650M-$750M Florida Land Portfolio Takes Center Stage
Key Points
- Interested in Alico, Inc.? Here are five stocks we like better.
- Alico has exited citrus production and is no longer operating as a citrus company, shifting instead to leasing land
This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
Key Points
- Interested in iShares Expanded Tech Sector ETF? Here are five stocks we like better.
- The iShares North American Tech ETF (IGM) has posted a year-to-date gain of nearly 20%, outpacing
Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions
Key Points
- Interested in Alvotech? Here are five stocks we like better.
- Alvotech said it is entering a “critical inflection period” as several biosimilars move through FDA review, with
Micron & 2 Momentum Stocks to Buy Now for Explosive Upside
Investors now aiming for exceptional returns should concentrate on high-momentum stocks. To uncover stocks with further upside potential, they can follow Richard Driehaus’s famous “buy high and sell
Why It May Be the Right Time to Book Profits in IonQ Stock
Despite a turbulent start to 2026 for technology stocks, IonQ IONQ has significantly outperformed both the broader market and many of its quantum computing peers. The stock is up 33.3% year to date
Intel Is the Market's Most Mispriced AI Hedge
Key Points
- Interested in Intel Corporation? Here are five stocks we like better.
- Alphabet is placing a massive, multi-year order for its custom AI chips with Intel, validating the foundry's
FuelCell Q2 Earnings Miss: What Drove the Weak Quarter?
FuelCell Energy FCEL posted a second-quarter fiscal 2026 adjusted loss of 58 cents per share, wider than the Zacks Consensus Estimate of a 54-cent loss. The underperformance was tied largely to
The Biggest Opportunity From SpaceX’s IPO May Surprise You
Key Points
- Interested in Redwire Corporation? Here are five stocks we like better.
- The SpaceX IPO is more than four times oversubscribed, leaving an estimated $225 billion in sidelined capital to
2 Highly Ranked Stocks to Consider After May's Hot CPI Report: DOW, GLP
Inflation concerns returned to center stage on Wednesday after May's Consumer Price Index (CPI) report showed that U.S. consumer prices have continued to soar.
Headline CPI rose 4.2% year over year,
Here's Why Investors Continue to Hold Ensign Group Stock
The Ensign Group, Inc. ENSG remains well positioned to benefit from favorable demographic and post-acute care trends, supported by rising occupancy and patient volumes. Headquartered in San Juan
EHC Expands Georgia Footprint With New 40-Bed Rehab Hospital
Encompass Health Corporation EHC continues to expand its inpatient rehabilitation footprint with the opening of Eastside Rehabilitation Hospital in Loganville, GA. The more than 52,000-square-foot
Can Gilead Sciences HIV Franchise Drive Long-Term Growth?
Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy for treatment and Descovy for prevention.
Last month, the company reported
Tetra Tech Secures Contract for Columbia River Dam Upgrades
Tetra Tech, Inc. TTEK has secured a contract from Chelan County Public Utility District (PUD) for the Hydropower Dam Spillway Modernization Project at the Rock Island and Rocky Reach hydroelectric
AXT's $100M Backlog Sounds Bullish, But Can Export Risks Derail Growth?
AXT AXTI is benefiting from a strong artificial intelligence-driven demand cycle, as evident in its first-quarter results. The most eye-catching metric was its record indium phosphide backlog, which
OGE Energy Benefits From Data Center Growth and Renewable Expansion
OGE Energy Corp. OGE continues to benefit from its strategic investments, which are focused on infrastructure upgradation. The company also stands to benefit from its efforts to expand its renewable
Is Intuitive Machines Building a More Diversified Revenue Model?
Intuitive Machines, Inc. LUNR has traditionally been viewed as a lunar exploration company. While lunar missions remain an important part of its long-term strategy, the company is increasingly
Alkermes Touts Orexin Ambitions as Alixorexton Enters Phase 3 and CEO Transition Nears
Key Points
- Interested in Alkermes plc? Here are five stocks we like better.
- Alkermes’ lead orexin agonist, alixorexton, has entered Phase 3 with the Brilliance program now enrolling in
Palantir's AIPCon Shows Why Customers Are Fueling the Bull Case
Key Points
- Interested in Palantir Technologies Inc.? Here are five stocks we like better.
- Customer testimonials at AIPCon reinforced growing adoption of Palantir's AI platform across multiple
WFC Stock Rises as CFO Sees Stronger Q2 NII, Reaffirms $50B 2026 Target
Shares of Wells Fargo & Company WFC rose nearly 1.3% after its chief financial officer (CFO), Mike Santomassimo, expressed confidence in the company’s net interest income (NII) outlook at the Morgan
SYPR Downgraded to Underperform on Margin Pressure, Liquidity Concerns
Sypris Solutions, Inc. SYPR has been downgraded to Underperform from Neutral following a disappointing first-quarter 2026 performance marked by declining sales, widening losses and mounting margin
UBS Group Stock Climbs 1.2% as Swiss Regulators Weigh Capital Relief
Shares of UBS Group AG UBS rose 1.2% following reports that Swiss lawmakers are considering fresh proposals to ease capital requirements imposed on the bank under Switzerland's banking reform
Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?
ANI Pharmaceuticals ANIP is executing a clear pivot toward higher-margin specialty revenues, led by Purified Cortrophin Gel. That momentum is now showing up in earnings power and a higher 2026
ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push
ANI Pharmaceuticals ANIP is leaning harder into its Rare Disease franchise as growth increasingly concentrates around Purified Cortrophin Gel. The next step is a sharper commercial push into acute
Here's Why Investors Should Add J.B. Hunt Stock to Their Portfolio
J.B. Hunt Transportation (JBHT) performed well in the past year and has the potential to sustain the momentum in the future. If you have not taken advantage of its share price appreciation yet, it’s